HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account

Clinical Expertise

Dr. Lee Sherick's primary research focus is to harness the immune system to more effectively cure acute leukemia. The Lee Sherick lab explores the role that tolerogenic macrophages and dendritic cells play in immune evasion of leukemia and how this can be reversed. One such approach is by inhibiting efferocytosis by blocking phosphatidyl serine receptors (such as MerTK) on macrophages and dendritic cells, which results in an anti-tumor microenvironment and decreases immune evasion. The hope is that the knowledge gained from this research can be used to develop novel immunotherapeutic approaches to treat acute leukemias.


Education and fellowships

  • Undergraduate 1999

University of Minnesota–Twin Cities (MN)

  • Medical Education 2006

University of Minnesota Medical School

  • Internship 2007

Children's Hospital of Orange County Program

  • Residency 2009

Oregon Health & Science University

  • Fellowship 2012

University of Colorado (Children's Hospital Colorado) Program

Awards and recognitions 

  • Pediatric Scientist Development Program Fellow 2013

The Association of Medical School Pediatric Department Chairs Inc. (AMSPDC)

  • Scholar 2015

University of Colorado Department of Pediatrics K12

  • Junior Faculty Scholar 2018

American Society of Hematology

  • Young Physician-Scientist Award 2019

American Society for Clinical Investigation



Children's Hospital Colorado - Center for Cancer and Blood Disorders : 13123 E 16th Ave, Aurora, CO 80045, USA

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Jazz Pharmaceuticals
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube